| TIL |
Instil Bio, Inc. |
0 |
3.59% |
|
|
|
|
|
N/A |
0.00% |
576.12% |
75.97% |
|---|
| REPL |
Replimune Group, Inc. |
0 |
3.54% |
|
|
|
|
|
N/A |
0.00% |
160.98% |
66.60% |
|---|
| IOVA |
Iovance Biotherapeutics, Inc. |
0 |
3.47% |
|
|
|
|
|
N/A |
0.00% |
N/A |
49.63% |
|---|
| ZYME |
Zymeworks Inc. |
0 |
3.45% |
|
|
|
|
|
N/A |
0.00% |
270.17% |
51.11% |
|---|
| ARGX |
argenx SE |
0 |
3.42% |
|
|
|
|
|
N/A |
0.00% |
38.30% |
57.69% |
|---|
| GMAB |
Genmab A/S |
0 |
3.42% |
|
|
|
|
|
N/A |
0.00% |
46.46% |
33.39% |
|---|
| AZN |
AstraZeneca PLC |
0 |
3.39% |
|
|
|
|
|
N/A |
0.00% |
28.97% |
41.12% |
|---|
| BMY |
Bristol-Myers Squibb Company |
0 |
3.39% |
|
|
|
|
|
N/A |
0.00% |
36.45% |
41.73% |
|---|
| CRSP |
CRISPR Therapeutics AG |
0 |
3.39% |
|
|
|
|
|
N/A |
0.00% |
64.73% |
47.99% |
|---|
| MRK |
Merck & Co., Inc. |
0 |
3.37% |
|
|
|
|
|
N/A |
0.00% |
38.21% |
49.82% |
|---|
| NKTR |
Nektar Therapeutics |
0 |
3.37% |
|
|
|
|
|
N/A |
0.00% |
87.07% |
3.50% |
|---|
| XNCR |
Xencor, Inc. |
0 |
3.37% |
|
|
|
|
|
N/A |
0.00% |
N/A |
30.50% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
3.36% |
|
|
|
|
|
N/A |
0.00% |
42.95% |
59.51% |
|---|
| FATE |
Fate Therapeutics, Inc. |
0 |
3.33% |
|
|
|
|
|
N/A |
0.00% |
197.80% |
25.90% |
|---|
| GILD |
Gilead Sciences, Inc. |
0 |
3.33% |
|
|
|
|
|
N/A |
0.00% |
33.35% |
50.53% |
|---|
| RCUS |
Arcus Biosciences, Inc. |
0 |
3.32% |
|
|
|
|
|
N/A |
0.00% |
723.42% |
55.65% |
|---|
| ATRA |
Atara Biotherapeutics, Inc. |
0 |
3.30% |
|
|
|
|
|
N/A |
0.00% |
769.79% |
94.72% |
|---|
| ALLO |
Allogene Therapeutics, Inc. |
0 |
3.29% |
|
|
|
|
|
N/A |
0.00% |
594.89% |
73.32% |
|---|
| RUBY |
Rubius Therapeutics, Inc. |
|
3.29% |
|
|
|
|
|
|
|
|
|
|---|
| TRIL |
Trillium Therapeutics Inc. |
|
3.29% |
|
|
|
|
|
|
|
|
|
|---|
| BLUE |
bluebird bio, Inc. |
|
3.28% |
|
|
|
|
|
|
|
|
|
|---|
| IBRX |
ImmunityBio, Inc. |
0 |
3.28% |
|
|
|
|
|
N/A |
0.00% |
118.68% |
66.68% |
|---|
| IMAB |
I-Mab |
0 |
3.25% |
|
|
|
|
|
N/A |
0.00% |
314.71% |
58.05% |
|---|
| IGMS |
IGM Biosciences, Inc. |
0 |
3.23% |
|
|
|
|
|
N/A |
0.00% |
77.27% |
100.00% |
|---|
| STTK |
Shattuck Labs, Inc. |
0 |
3.23% |
|
|
|
|
|
N/A |
0.00% |
N/A |
64.81% |
|---|
| ALXO |
ALX Oncology Holdings Inc. |
0 |
3.21% |
|
|
|
|
|
N/A |
0.00% |
419.97% |
64.34% |
|---|
| LEGN |
Legend Biotech Corporation |
0 |
3.20% |
|
|
|
|
|
N/A |
0.00% |
63.85% |
31.82% |
|---|
| BGNE |
BeiGene, Ltd. |
|
3.19% |
|
|
|
|
|
|
|
|
|
|---|
| MGNX |
MacroGenics, Inc. |
0 |
3.17% |
|
|
|
|
|
N/A |
0.00% |
626.17% |
32.41% |
|---|
| YMAB |
Y-mAbs Therapeutics, Inc. |
0 |
3.12% |
|
|
|
|
|
N/A |
0.00% |
598.67% |
54.33% |
|---|
| Cash&Other |
|
|
0.13% |
|
|
|
|
|
|
|
|
|
|---|